Insider Trading & Ownership of Scott Myers

Location: C/O Cascadian Therapeutics, Inc., 3101 Western Ave., Suite 600, Seattle, WA
Summary: The estimated net worth of Scott Myers is at least $6.23M dollars as of August 25, 2025. Scott Myers is the Chief Executive Officer, Director of Viridian Therapeutics, Inc.\DE and owns shares of Viridian Therapeutics, Inc.\DE (VRDN) stock worth about $5.45M. Scott Myers is the Director of Zentalis Pharmaceuticals, Inc. and owns shares of Zentalis Pharmaceuticals, Inc. (ZNTL) stock worth about $403K. Scott Myers is the Director of DYNAVAX TECHNOLOGIES CORP and owns shares of DYNAVAX TECHNOLOGIES CORP (DVAX) stock worth about $379K.
Signature: Scott Myers, by /s/ Trevor Dutcher, Attorney-in-Fact
All Insider Reports: All Insider Reports

Notify me when Scott Myers files a new Insider Trading report.

Ownership of Scott Myers

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
VRDN	Viridian Therapeutics, Inc.\DE	Chief Executive Officer, Director	$5.45M			Apr 12, 2023
ZNTL	Zentalis Pharmaceuticals, Inc.	Director	$403K	+$29.4K	+7.86%	Jun 17, 2025
DVAX	DYNAVAX TECHNOLOGIES CORP	Director	$379K	+$41.1K	+12.2%	Aug 22, 2025
RNAC	Cartesian Therapeutics, Inc.	Director				Nov 13, 2023
HARP	Harpoon Therapeutics, Inc.	Director				Mar 11, 2024
TRIL	Trillium Therapeutics Inc.	Director				Nov 17, 2021

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.